Evidence map›Paper›PMID 35698242›Full record

ArticleGenome medicine2022

Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome.

Margot A Cousin, Emma L Veale, Nikita R Dsouza, Swarnendu Tripathi, Robyn G Holden, Maria Arelin, Geoffrey Beek, Mir Reza Bekheirnia, Jasmin Beygo, Vikas Bhambhani and 61 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Assessing Protein Surface-Based Scoring for Interpreting Genomic Variants.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. C-type inactivation and proton modulation mechanisms of the TASK3 channel.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. AFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

71 authors at 20 institutions in 9 countries.

Margot A Cousin *Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-6119-9346
Emma L Veale *Medway School of Pharmacy, University of Kent and University of Greenwich, Central Avenue, Anson Building, Central Avenue, Chatham Maritime, ME4 4, Kent, TB, ME4 4 TB, UK.ORCID 0000-0002-6778-9929
Nikita R DsouzaBioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Swarnendu TripathiBioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Robyn G HoldenMedway School of Pharmacy, University of Kent and University of Greenwich, Central Avenue, Anson Building, Central Avenue, Chatham Maritime, ME4 4, Kent, TB, ME4 4 TB, UK.
Maria ArelinDepartment for Women and Child Health, Hospital for Children and Adolescents, University Hospitals, University of Leipzig, Leipzig, Germany.
Geoffrey BeekChildren's Hospital of Minnesota, Minneapolis, MN, USA.
Mir Reza BekheirniaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Jasmin BeygoInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Vikas BhambhaniChildren's Hospital of Minnesota, Minneapolis, MN, USA.
Martin BialerDivision of Medical Genetics, Northwell Health, Manhasset, NY, USA.
Stefania BigoniMedical Genetics Unit, Department of Medical Sciences, Ferrara University, Ferrara, Italy.
Cyrus BoelmanDivision of Neurology, BC Children's Hospital, Vancouver, British Columbia, Canada.
Jenny CarmichaelOxford Centre for Genomic Medicine, ACE Building, Nuffield Orthopaedic centre, Oxford University Hospitals NHS Foundation Trust, Windmill road, Headington, Oxford, OX3 7HE, UK.
Thomas CourtinDépartement of Genetics, APHP, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.
Benjamin CogneCHU Nantes, Service de génétique médicale, Nantes, France.
Ivana DabajCHU de Rouen, Service de Néonatologie, Réanimation pédiatrique, Neuropédiatrie et éducation fonctionnelle de l'enfant, INSERM U 1245, ED497, 76000, Rouen, France.
Diane DoummarAPHP, Department of Neuropediatrics, National Reference Center for Neurogenetic Disorders, Hôpital Armand-Trousseau, GHUEP, Paris, France.
Laura FazilleauService de Néonatologie, CHU de Caen, Caen, France.
Alessandra FerliniMedical Genetics Unit, Department of Medical Sciences, Ferrara University, Ferrara, Italy.ORCID 0000-0001-8385-9870
Ralitza H GavrilovaCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
John M GrahamDepartment of Pediatrics, Harbor-UCLA Medical Center, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Tobias B HaackCentre for Rare Diseases, University of Tübingen, Tübingen, Germany.
Jane JuusolaGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Sarina G KantDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Saima KayaniDepartments of Pediatrics and Neurology, University of Texas Southwestern Medical Center and Children's Health, Dallas, TX, USA.
Boris KerenAPHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651, Paris, France.
Petra KettelerInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Chiara KlöcknerInstitute of Human Genetics, University of Leipzig Medical Center, 04103, Leipzig, Germany.
Tamara T KoopmannDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Teresa M KruisselbrinkCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Alma KuechlerInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Laëtitia LambertService de Genetique Clinique, CHRU de Nancy, F-54000, Vandoeuvre-les-Nancy, France.
Xénia LatypovaCHU Nantes, Service de génétique médicale, Nantes, France.
Robert Roger LebelSection of Medical Genetics, SUNY Upstate University Hospital, Syracuse, NY, USA.
Magalie S LeducDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Emanuela LeonardiMolecular Genetics of Neurodevelopmental Disorders, Department of Woman and Child Health, University of Padova, Padua, Italy.
Andrea M LewisDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Wendy LiewDepartment of Paediatric Medicine, KK Women's and Children's Hospital, Mount Elizabeth Hospital, Singapore, Singapore.
Keren MacholDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Samir MardiniDivision of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, MN, USA.
Kirsty McWalterGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Cyril MignotAPHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651, Paris, France.
Julie McLaughlinDivision of Medical Genetics, Northwell Health, Manhasset, NY, USA.
Alessandra MurgiaMolecular Genetics of Neurodevelopmental Disorders, Department of Woman and Child Health, University of Padova, Padua, Italy.
Vinodh NarayananCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, AZ, USA.
Caroline NavaAPHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75651, Paris, France.
Sonja NeuserInstitute of Human Genetics, University of Leipzig Medical Center, 04103, Leipzig, Germany.
Mathilde NizonCHU Nantes, Service de génétique médicale, Nantes, France.
Davide OgnibeneMedical Genetics Unit, Department of Medical Sciences, Ferrara University, Ferrara, Italy.
Joohyun ParkInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Konrad PlatzerInstitute of Human Genetics, University of Leipzig Medical Center, 04103, Leipzig, Germany.ORCID 0000-0001-6127-6308
Céline PoirsierDepartment of Genetics, Reims University Hospital, Reims, France.
Maximilian RadtkeInstitute of Human Genetics, University of Leipzig Medical Center, 04103, Leipzig, Germany.
Keri RamseyCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, AZ, USA.
Cassandra K RunkeDepartment of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Maria J Guillen SacotoGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Fernando ScagliaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Marwan ShinawiDepartment of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MT, USA.
Stephanie SprangerPractice of Human Genetics, Bremen, Germany.
Ee Shien TanDepartment of Paediatric Medicine, KK Women's and Children's Hospital, Mount Elizabeth Hospital, Singapore, Singapore.
John TaylorOxford Centre for Genomic Medicine, ACE Building, Nuffield Orthopaedic centre, Oxford University Hospitals NHS Foundation Trust, Windmill road, Headington, Oxford, OX3 7HE, UK.
Anne-Sophie TrentesauxService de Néonatologie, CHU de Caen, Caen, France.
Filippo VairoCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Rebecca WillaertGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Neda ZadehGenetics Center, Orange, CA, USA.
Raul UrrutiaBioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Dusica Babovic-VuksanovicCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Michael T ZimmermannBioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. mtzimmermann@mcw.edu.ORCID 0000-0001-7073-0525
Alistair MathieMedway School of Pharmacy, University of Kent and University of Greenwich, Central Avenue, Anson Building, Central Avenue, Chatham Maritime, ME4 4, Kent, TB, ME4 4 TB, UK. a.a.mathie@kent.ac.uk.ORCID 0000-0001-6094-2890
Eric W KleeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA. klee.eric@mayo.edu.ORCID 0000-0003-2946-5795
Mayo Clinic · USBaylor College of Medicine · USSorbonne Université · FRLeipzig University · DEMedical College of Wisconsin · USGénétique Médicale & Génomique Fonctionelle · FRUniversity of Ferrara · ITCentre Hospitalier Universitaire de Caen Normandie · FRInserm · FRLeiden University Medical Center · NLMedway School of Pharmacy · GBMount Elizabeth Hospital · SGNorthwell Health · USNuffield Orthopaedic Centre · GBTranslational Genomics Research Institute · USUniversity of Duisburg-Essen · DEUniversity of Minnesota Children's Hospital · USUniversity of Padua · ITUniversity of Tübingen · DEBC Children's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenomics enables individualized diagnosis and treatment, but large challenges remain to functionally interpret rare variants. To date, only one causative variant has been described for KCNK9 imprinting syndrome (KIS). The genotypic and phenotypic spectrum of KIS has yet to be described and the precise mechanism of disease fully understood.

methodsThis study discovers mechanisms underlying KCNK9 imprinting syndrome (KIS) by describing 15 novel KCNK9 alterations from 47 KIS-affected individuals. We use clinical genetics and computer-assisted facial phenotyping to describe the phenotypic spectrum of KIS. We then interrogate the functional effects of the variants in the encoded TASK3 channel using sequence-based analysis, 3D molecular mechanic and dynamic protein modeling, and in vitro electrophysiological and functional methodologies.

resultsWe describe the broader genetic and phenotypic variability for KIS in a cohort of individuals identifying an additional mutational hotspot at p.Arg131 and demonstrating the common features of this neurodevelopmental disorder to include motor and speech delay, intellectual disability, early feeding difficulties, muscular hypotonia, behavioral abnormalities, and dysmorphic features. The computational protein modeling and in vitro electrophysiological studies discover variability of the impact of KCNK9 variants on TASK3 channel function identifying variants causing gain and others causing loss of conductance. The most consistent functional impact of KCNK9 genetic variants, however, was altered channel regulation.

conclusionsThis study extends our understanding of KIS mechanisms demonstrating its complex etiology including gain and loss of channel function and consistent loss of channel regulation. These data are rapidly applicable to diagnostic strategies, as KIS is not identifiable from clinical features alone and thus should be molecularly diagnosed. Furthermore, our data suggests unique therapeutic strategies may be needed to address the specific functional consequences of KCNK9 variation on channel function and regulation.

Indexed as

Intellectual DisabilityPotassium Channels, Tandem Pore DomainGenotypeHumansMuscle HypotoniaMutationPhenotypeKCNK9 protein, humanPotassium Channels, Tandem Pore DomainComputational protein modelingElectrophysiologyKCNK9 imprinting syndromeNeurodevelopmental disorderTASK3 channel

Identifiers

PMID35698242
PMCPMC9195326
OpenAlexW4282546381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.